Patient Engagement Can Cut Costs, Improve Outcomes
Initiatives can decrease hospital visits, cut morbidity and mortality, up treatment adherence
PDE-5 Inhibitors Tied to Prostate Cancer Biochemical Recurrence
Phosphodiesterase type 5 inhibitors up risk of biochemical recurrence after radical prostatectomy
CDC: ~8 Percent of U.S. Adults Nonadherent Due to Rx Costs
Patients skipping doses, taking less medication or delaying filling prescriptions
Current Smoking Reduces Survival in Prostate Cancer
Former, as well as current, smokers saw higher risk for radiation tx-related urinary side effects
Cumulative Use of Anticholinergic Medication Tied to Dementia
Class of drugs interferes with a key brain chemical, but study doesn't prove cause and effect
Chlorhexidine Bathing Doesn’t Cut Health Care-Linked Infections
No difference in primary outcome for bathing with chlorhexidine versus nonantimicrobial cloth
MRI-Targeted Prostate Biopsy May Yield Better Results
Spots more aggressive cancer, but fewer low-risk cases
Prophylactic Antimicrobials Overused in Urologic Surgery
In community practice, overall rate of compliance with AUA Best Practices is less than 60 percent
ASCO Reports Biggest Clinical Cancer Advances for 2015
The advance of the year is approval of four new therapies for treatment of CLL
May Be Room for Improvement in U/S Transducer Hygiene
Research indicates some institutions use cover materials of unacceptable permeability
